Labiotech.eu

News and Trends 2 Nov 2015

How Big can be Small in Biotech – #BIO-Europe 2015 Keynote

As usual at BIO-Europe, the fair starts with an opening keynote, this time with speakers from Merck Healthcare, MedImmune/AstraZeneca and Baxalta. The keynote is basically a discussion between high-level speakers, akin to the talk which took place in Paris during March, when Antoine Papiernik (the prominent European VC from Sofinnova) led a panel discussion with […]

November 2, 2015 - 5 minutesmins - By Philip Hemme

News and Trends 2 Nov 2015

A Glimpse into the DIY Biotech Movement: Biohacking, Vegan Cheese, Algae Beer and Bacterial Art!

Fab Labs have become hugely fashionable since 2010… But what about Bio Fab Labs? Have you ever thought about sharing your RNA or DNA amplification equipment? It can be a massive help for entrepreneurs or students, and Bio Fab Labs are starting to emerge in backyards across the world for Education, Innovation and even creative SynBio art. This new era of DIY […]

November 2, 2015 - 6 minutesmins - By Julie Lellouche

News and Trends 2 Nov 2015

EU’s biggest Biotech Fair, BIO-Europe 2015, is starting … NOW!

The European ecosystem of Biotech will be for the next three days in Munich, Germany. That’s where the BIO-Europe 2015 convention takes place. Yesterday, with Joachim and Will, we drove south from Berlin to Munich to be on-site for the start of the event. This morning, the alarm was set up early and we had to […]

November 2, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 2 Nov 2015

The French Scientist Who Also ‘Discovered’ CRISPR is Finally Recognized with a Prize too

So, we all know the CRISPR Success story with Emmanuelle Charpentier & Jennifer Doudna, who have received multiple awards and constant celebration of their pioneering work in 2012. However, what about the guy who really first described the CRISPR-Cas9 mechanism all the way back in 2007? Finally, he gets some recognition too. Senior DuPont scientist […]

November 2, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 31 Oct 2015

What Happened this Week? An Incredible Woman, CRISPR deal, CAR-T milestone

Monday: Wow, Europe’s leading CRISPR Biotech signs monster €2.29 Billion Deal Tuesday: Meet the French Woman who started a Biotech to Save her Daughter from a Rare Disease Wednesday: Dragen Bio-Processor: UK Partnership to Finally Sequence Domestic Wheat Genome Thursday: Cellectis UCART Milestone: One step closer to a Universal CAR-T Therapy for Blood Cancer Friday: Purple GMO Tomatoes […]

October 31, 2015 - 1 minutemin - By Philip Hemme

News and Trends 30 Oct 2015

Grifols takes a nice €100M slice for Alzheimer’s from EU €315 Billion Investment Offensive

A huge European action for the next three following years is the European Fund for Strategic Investments (aka the Juncker plan). This consists of a €315 billion Investment Plan to “get Europe growing and more people back to work” (as written on Europa’s website). The Barcelonan Grifols (Spain) is one of the first companies to receive its […]

October 30, 2015 - 2 minutesmins - By Jerome Topsent

News and Trends 30 Oct 2015

Purple GMO Tomatoes are Growing Medicines in the UK

Meet the purple tomatoes which produce as much Revervesterol in a single fruit as 50 bottles of wine, and as much anti-breast cancer chemical as 2.5Kg of Tofu! The John Innes Centre in Norwich (East England) have engineered these tomato plants to produce larger amounts of these health-related compounds. With funding from the Biotechnology and […]

October 30, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 30 Oct 2015

Biotech of the week: Sanifit from Mallorca and its novel take on calcification disorders

This week we say ciao to Milan and head South-West, across the Mediterranean Sea and say hola to the the largest island in the Balearic Islands archipelago, Mallorca. This island is famous for its picturesque white beaches, brilliant weather and being the main vacation destination for the younger generations. It is also home to our […]

October 30, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 29 Oct 2015

To beat J&J, Pfizer attempts a New Merger…Guess who’s the Target this Time?!

Mergers & acquisitions (or M&A in short) have ruled the world of Pharma for a while and the company which seems to be the most hungry this year is Pfizer! After it failed to buy AstraZeneca in May 2015 for $118Bn (woah!!), the company is still trying to become the biggest Pharma company worldwide… This time, the target is Allergan. This company […]

October 29, 2015 - 2 minutesmins - By Jerome Topsent

News and Trends 29 Oct 2015

Naughty Novartis…US Department of Justice Fines them $390M – Again!

Being a multi-billion international Pharmaceutical giant does not protect you from the Law…and in my best American accent “Justice WILL be served” (and bang! goes the gavel). Novartis gets called out on their dodgy sales boosting techniques again down the US Federal court. Novartis has been caught out serving Pharmacists and Doctors under the table […]

October 29, 2015 - 3 minutesmins - By Dani Bancroft

News and Trends 29 Oct 2015

Cellectis UCART Milestone: One step closer to a Universal CAR-T Therapy for Blood Cancer

Cellectis is a leader in immuno-oncology CAR-T therapies from France, which might revolutionise cancer treatments. Now, the next step in the CAR-T campaign is to step away from personalised (autologous) therapies, which are time-consuming and expensive, to instead produce an allogenic version available to all. So, what is CAR-T? You can read a more in-depth […]

October 29, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 29 Oct 2015

ERRATUM: Celyad’s US patent on TCR-deficient allogeneic CAR-T cells

ERRATUM: I published a first article on Celyad’s new patent on last Tuesday where I made an error of judgement. Celyad’s US patent covers allogeneic CAR-T modified to reduce immunogenicity. In my previous article, I wrote that Celyad stated having obtained the first US patent on CAR-T, which is wrong. Last Tuesday, Celyad announced having […]

October 29, 2015 - 3 minutesmins - By Philip Hemme

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

How Big can be Small in Biotech – #BIO-Europe 2015 Keynote

A Glimpse into the DIY Biotech Movement: Biohacking, Vegan Cheese, Algae Beer and Bacterial Art!

EU’s biggest Biotech Fair, BIO-Europe 2015, is starting … NOW!

The French Scientist Who Also ‘Discovered’ CRISPR is Finally Recognized with a Prize too

What Happened this Week? An Incredible Woman, CRISPR deal, CAR-T milestone

Grifols takes a nice €100M slice for Alzheimer’s from EU €315 Billion Investment Offensive

Purple GMO Tomatoes are Growing Medicines in the UK

Biotech of the week: Sanifit from Mallorca and its novel take on calcification disorders

To beat J&J, Pfizer attempts a New Merger…Guess who’s the Target this Time?!

Naughty Novartis…US Department of Justice Fines them $390M – Again!

Cellectis UCART Milestone: One step closer to a Universal CAR-T Therapy for Blood Cancer

ERRATUM: Celyad’s US patent on TCR-deficient allogeneic CAR-T cells

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!